188 related articles for article (PubMed ID: 21573834)
21. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
[TBL] [Abstract][Full Text] [Related]
22. [Related factors and prognosis of hepatic metastasis and peritoneal dissemination in gastric cancer].
Wang Z; Zhan WH; He YL; Cai SR; Peng JS; Chen CQ; Ma JP; Zheng ZQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):287-90. PubMed ID: 16886104
[TBL] [Abstract][Full Text] [Related]
23. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
24. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
25. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
26. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
28. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
29. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
30. The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients.
Makino T; Fujiwara Y; Takiguchi S; Miyata H; Yamasaki M; Nakajima K; Nishida T; Mori M; Doki Y
Surgery; 2010 Jul; 148(1):96-102. PubMed ID: 20096433
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of T antigen expression in patients with gastric carcinoma.
Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
[TBL] [Abstract][Full Text] [Related]
33. Is extended lymphadenectomy valuable in palliatively gastrectomized patients with gastric cancer and simultaneous peritoneal metastasis?
Kikuchi S; Arai Y; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Hiki Y; Kakita A
Hepatogastroenterology; 2000; 47(32):563-6. PubMed ID: 10791239
[TBL] [Abstract][Full Text] [Related]
34. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
35. [Role of peritoneal lavage smears and gastric wall brushing smears in gastric cancer surgery].
Shirakawa T; Onda M; Tokunaga A; Fujita I; Teramoto T; Takita M; Oguri T; Okuda T; Kiyama T; Yoshiyuki T; Kato S; Miyashita M; Naito Z; Matsukura N; Yamashita K; Asano G
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1472-5. PubMed ID: 8854783
[TBL] [Abstract][Full Text] [Related]
36. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
[TBL] [Abstract][Full Text] [Related]
38. Expression of ERas oncogene in gastric carcinoma.
Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
[TBL] [Abstract][Full Text] [Related]
39. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
Ueno H; Yoshida K; Hirai T; Kono F; Kambe M; Toge T
Anticancer Res; 2003; 23(2C):1701-8. PubMed ID: 12820444
[TBL] [Abstract][Full Text] [Related]
40. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]